メニュー →
サイト内検索結果 「」
全16,951件中、3,241件~3,260件を表示しています。
[1] ・・・ [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] ・・・ [848]
[1] ・・・ [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] ・・・ [848]
6481.
[生薬成分の代謝] 代謝物『3-(4-hydroxyphenyl)chroman-4,5,7-triol』
3-(4-hydroxyphenyl)chroman-4,5,7-triol 3-(4-hydroxyphenyl)chroman-4,5,7-triol C15H14O5 274.273 274.0841 275.092 273.0763 Genistein 代謝物
6482.
[生薬成分の代謝] 代謝物『(2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3,5,7-triol』
(2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3,5,7-triol (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3,5,7-triol C15H14O6 290.273 290.079 291.0869 289.0712 Epicatechin 3-O-gallate 代謝物
6483.
[生薬成分の代謝] 代謝物『(3S,4aR,5aS,6S,9R,9aR,11bR)-9-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-9a,11b-dimethyl-1,2,3,4,5a,6,7,8,9,9a,10,11,11a,11b-tetradecahydrocyclopenta[1,2]phenanthro[8a,9-b]oxirene-3,6-diol』
(3S,4aR,5aS,6S,9R,9aR,11bR)-9-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-9a,11b-dimethyl-1,2,3,4,5a,6,7,8,9,9a,10,11,11a,11b-tetradecahydrocyclopenta[1,2]phenanthro[8a,9-b]oxirene-3,6-diol (3S,4aR,5aS,6S,
6484.
[生薬成分の代謝] 代謝物『Saligenin』
2-(hydroxymethyl)phenol Saligenin 90-01-7 C7H8O2 124.139 124.0524 125.0603 123.0446 Salicin 代謝物
6485.
[生薬成分の代謝] 代謝パラメータ『Oral administration』
Oral administration 50 mg/kg N.D. N.D. 0-10 h N.D. : not detected. Saikosaponin 代謝パラメータ
6486.
[生薬成分の代謝] 代謝パラメータ『Oral administration』
Oral administration 6.4 ± 2.3 h 0.75 ± 0.27 h 1484.2 ± 240.9 ng/mL 7091.4 ± 1158.1 ng/mLxh
7284.1 ± 1186.3 ng/mLxh 0-t
0― Geniposide 代謝パラメータ
6487.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 0.02 mg/kg 56 ± 12 ng/ml 0.049 ± 0.007 min^-1 16 ± 2 min 3.4 ± 0.9 ng/ml 0.004 ± 0.001 min^-1 246 ± 91.3 min 0.41 ± 0.09 l/kg 1.7 ± 0.4 l/kg 10 ± 2 mlkg^-1min^-1 2055
6488.
[生薬成分の代謝] 代謝パラメータ『Oral administration』
Oral administration 3.0 mg/kg 1.94 ± 0.40 1/h 1.08 ± 0.31 h 77.64 ± 21.34 ng/ml 769.1 ± 238.5 ng h/ml 0-48 21.3 ± 0.8 h Each value represents the mean±S.D. of six rats. Benzoylmesaconine
6489.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 1.0 mg/kg 1169.2 ± 320.1 ng/ml 3.89 ± 0.67 h^-1 0.18 ± 0.04 h 47.7 ± 10.33 ng/ml 0.33 ± 0.02 h^-1 2.12 ± 0.53 h 0.82 ± 0.04 l/kg 3.13 ± 0.76 l/kg 1.03 ± 0.34 ml/h kg 96
6490.
[生薬成分の代謝] 代謝物『Mandelonitrile』
2-hydroxy-2-phenylacetonitrile Mandelonitrile 532-28-5 C8H7NO 133.15 133.0528 134.0606 132.0449 Amygdalin 代謝物
6491.
[生薬成分の代謝] 代謝物『Norathyriol』
1,3,6,7-tetrahydroxy-9H-xanthen-9-one Norathyriol 3542-72-1 C13H8O6 260.203 260.0321 261.0399 259.0243 Mangiferin 代謝物
6492.
[生薬成分の代謝] 代謝物『carthamin』
Unable to generate chemical name carthamin 36338-96-2 C43H42O22 910.793 910.2168 911.2246 909.209 Safflor Yellow B 代謝物
6493.
[生薬成分の代謝] 代謝パラメータ『Oral administration』
Oral administration 0.12 ± 0.02 1/h 5.68 ± 0.65 h 0.33 ± 0.02 h 13.66 ± 1.71 μg/ml 69.8 ± 7.10 (μg/ml) x h
62.49 ± 6.67 (μg/ml) x h 0-∞
0-t Geniposide 代謝パラメータ
6494.
[生薬成分の代謝] 代謝物『16-Hydroxybrucine』
(4aR,4a1R,5aR,8aS,8a1S,15aS)-5a-hydroxy-10,11-dimethoxy-4a1,5,5a,7,8,8a1,15,15a-octahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinolin-14(4aH)-one 16-Hydroxybrucine 560-30-5 C
6495.
[生薬成分の代謝] 代謝物『(6R)-6-hydroxy-5-vinyl-5,6-dihydropyrano[3,4-c]pyran-1(3H)-one』
(6R)-6-hydroxy-5-vinyl-5,6-dihydropyrano[3,4-c]pyran-1(3H)-one (6R)-6-hydroxy-5-vinyl-5,6-dihydropyrano[3,4-c]pyran-1(3H)-one C10H10O4 194.187 194.0579 195.0657 193.0501 Gentiopicroside 代謝物
6496.
[生薬成分の代謝] 代謝物『16-Hydroxystrychine』
(4aR,4a1R,5aR,8aS,8a1S,15aS)-5a-hydroxy-4a1,5,5a,7,8,8a1,15,15a-octahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinolin-14(4aH)-one 16-Hydroxystrychine C21H22N2O3 350.417 350.
6497.
[生薬成分の代謝] 代謝マップ『Capillarisin』
Capillarisin ラット Capillarisin 18264991 1) Haitao Lv, Hui Sun, Xijun Wang, Wenjun Sun, Guozheng Jiao, Dixin Zhou, Li Zhao, Hongxin Cao, Guangmei Zhang, Simultaneous determination by UPLC–ESI-MS of sco
6498.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 0.2 mg/kg 128.12 ± 13.4 ng/ml 2.83 ± 0.54 h^-1 0.25 ± 0.10 h 4.65 ± 0.83 ng/ml 0.26 ± 0.01 h^-1 2.78 ± 0.48 h 1.53 ± 0.27 l/kg 14.1 ± 4.61 l/kg 3.69 ± 0.47 ml/h kg 54.2
6499.
[生薬成分の代謝] 代謝パラメータ『Intravenous administration』
Intravenous administration 0.005 mg/kg 2.63 ± 0.37 ng/ml 11.05 ± 3.04 h^-1 0.0652 ± 0.0179 h 0.12 ± 0.13 ng/ml 0.42 ± 0.18 h^-1 1.823 ± 0.767 h 0.397 ± 0.069 l/kg 4.620 ± 2.536 l/kg 1.704 ± 0.247
6500.
[生薬成分の代謝] 代謝パラメータ『Oral administration
paeoniflorin
』
Oral administration
paeoniflorin
5 mg/kg 13.3 ± 1.7 min 20.3 ± 2.7 ng/ml 1174 ± 287 ng・min/ml 0-180 Each point represents the mean ± S. E. (n=3). Paeoniflorin 代謝パラメータ
[1]
・・・
[158]
[159]
[160]
[161]
[162]
[163]
[164]
[165]
[166]
[167]
[168]
・・・
[848]
全16,951件中、3,241件~3,260件を表示しています。
全16,951件中、3,241件~3,260件を表示しています。